Metraipolis › archive › dc_bec60b1fa0f0
Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis — Europe PMC PMID:41897691
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41897691
- DOI
- 10.3390/diagnostics16060957
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T02:21:45.314Z
- SHA-256 of the archived text
86763476b0e6f47e3c6ec8e2914837ef936268ba5dde8c851d79e044dd47e0f9- Stable URL of this page
https://metraipolis.com/documento/dc_bec60b1fa0f0
How to cite
Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis — Europe PMC PMID:41897691 — Europe PMC (en), https://europepmc.org/article/MED/41897691 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bec60b1fa0f0 (Metraipolis archive dc_bec60b1fa0f0, sha256 86763476b0e6f47e3c6ec8e2914837ef936268ba5dde8c851d79e044dd47e0f9)
BibTeX
@misc{dcbec60b1fa0f0,
title = {Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis — Europe PMC PMID:41897691},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41897691},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bec60b1fa0f0; sha256 86763476b0e6f47e3c6ec8e2914837ef936268ba5dde8c851d79e044dd47e0f9},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41897691. Agents can read the archived copy with the MCP tool read_document.